En Carta Diagnostics
En Carta Diagnostics develops molecular diagnostic technologies that enable the detection of DNA and RNA pathogens at the point of care.
$1.63M Pre Seed ·
Source: startupintros.com
Latest round on record: Seed, July 2026, amount undisclosed.
All 2 rounds ↓Signals
En Carta Diagnostics | 412 days from X account to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | undisclosed | — | — | |
| Pre Seed | $1.63M | — | startupintros.com |
Timeline
- X account created
- Website created
Founders and team
GH
Guillaume Horreard FounderMK
Margot Karlikow Founder
Companies like En Carta Diagnostics
VVivid Dx$15M Seed · Jul 2026
DDetectPre Seed · Jun 2026IiPremom$17.37M Seed · Sep 2026
TTvaster Genkalp$1.25M Series A · Apr 2025
SSegnosSeed · Oct 2026
DDARO$2.5M Seed · Oct 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/en-carta-diagnostics (get a free API key).